Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Microb Genom ; 8(5)2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35622495

RESUMEN

Klebsiella pneumoniae (Kp) has emerged as a global life-threatening pathogen owing to its multidrug resistance and hypervirulence phenotype. Several fatal outbreaks of carbapenem-resistant hypervirulent Kp have been reported recently. Hypermucoviscosity (HMV) is a phenotype commonly associated with hypervirulence of Kp, which is usually regulated by rmpA or rmpA2 (regulators of the mucoid phenotype). Here, we found that temperature was important in the HMV phenotype of Kp, and the impact of temperature on HMV was not uniform among strains. We investigated the HMV phenotype at 37 °C and room temperature (20-25 °C) in 170 clinically isolated hypermucoviscous Kp strains in Japan and analysed the association between the HMV phenotype, virulence genes and antimicrobial resistance (AMR) genes. String length distribution at different temperatures was correlated with the genomic population of Kp. The strains carrying rmpA/rmpA2 frequently showed the HMV phenotype at 37 °C, while the strains negative for these genes tended to show the HMV phenotype at room temperature. Hypervirulent Kp clusters carrying rmpA/rmpA2 without extended-spectrum beta-lactamases (ESBL)/carbapenemases produced higher string lengths at 37 °C than at room temperature, and were mostly isolated from the respiratory tract. Other HMV strains showed distinct characteristics of not carrying rmpA/rmpA2 but were positive for ESBL/carbapenemases, with a higher string length at room temperature than at 37 °C, and were frequently isolated from bloodstream infections. In total, 21 (13.5 %) HMV isolates carried ESBL and carbapenemases, among which five isolates were carbapenem-resistant hypervirulent Kp with a pLVPK-like plasmid (an epidemic virulence plasmid) and a pKPI-6-like plasmid (an epidemic blaIMP-6-bearing plasmid in Japan), suggesting the convergence of worldwide hypervirulence and epidemic AMR in Japan.


Asunto(s)
Enterobacteriaceae Resistentes a los Carbapenémicos , Infecciones por Klebsiella , Carbapenémicos/farmacología , Genómica , Humanos , Japón/epidemiología , Infecciones por Klebsiella/epidemiología , Klebsiella pneumoniae , Temperatura
2.
J Infect Chemother ; 27(11): 1634-1638, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34376351

RESUMEN

INTRODUCTION: The carbapenem inactivation method test (CIM) was developed as a method for detecting carbapenemase-producing Gram-negative bacilli, and the modified CIM (mCIM) was recommended by the CLSI for as an improved method in M100-S27. However, few studies have evaluated the influence of bacterial species and genotype on its sensitivity and specificity. In this study, we evaluate the performance of these improved modified CIM methods with mCIM. METHODS: As strains, clinical isolates from Naga Municipal Hospital and stored strains from the Study of Bacterial Resistance in the Kinki Region of Japan were used. The mCIM, CIM-Tris, and simple CIM (sCIM) test methods were applied to 120 Enterobacterales, 40 Pseudomonas aeruginosa, and 37 Acinetobacter spp. The procedure and criteria for each method were based on the original papers and the CLSI M - 100 S27 documents. RESULTS: The sensitivity of the test methods in the detection of carbapenemase in Enterobacterales, Pseudomonas spp., and Acinetobacter spp. was as follows: mCIM, 98.9%, 90.0%, and 76.5%, respectively; CIM-Tris, 94.4%, 100%, 100%; and sCIM 98.9%, 85.0%, 76.5%. All methods showed 100% specificity in Enterobacterales, Pseudomonas spp., and Acinetobacter spp. Each method performed well in the detection of metallo ß-lactamase-producing strains, however, the sensitivity tended to be low in the detection of the organisms producing serine-type carbapenemase, such as GES, OXA-23, and OXA-51. CONCLUSIONS: Care must be taken when selecting test methods because the sensitivity of the detection differs depending on the bacterial species and genotype.


Asunto(s)
Carbapenémicos , beta-Lactamasas , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Carbapenémicos/farmacología , Humanos , Pruebas de Sensibilidad Microbiana , Sensibilidad y Especificidad , beta-Lactamasas/genética
3.
J Infect Chemother ; 25(11): 837-844, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31427200

RESUMEN

Obligate anaerobes exist as resident flora in various sites in humans, but they are also emphasized as endogenous causative microorganism of infections. We performed surveillance to understand the trend of drug susceptibility in obligate anaerobic bacteria in the Kinki area of Japan. In the experiment, we used 156 obligate anaerobe isolates collected from 13 institutions that participated in the Study of Bacterial Resistance Kinki Region of Japan. MALDI Biotyper was used to identify the collected strains, and among the 156 test strains, those that could be identified with an accuracy of Score Value 2.0 or more included 6 genera, 30 species, and 144 strains (Bacteroides spp. 77 strains, Parabacteroides sp. 2 strains, Prevotella spp. 29 strains, Fusobacterium spp. 14 strains, Porphyromonas spp. 2 strains, and Clostridioides difficile 20 strains), and they were assigned as subject strains for drug susceptibility testing. The drug susceptibility test was carried out by broth microdilution method using Kyokuto Opt Panel MP ANA (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) and judged according to CLSI criteria. As a result, Bacteroides and Parabacteroides species showed good sensitivities to tazobactam-piperacillin, imipenem, metronidazole and chloramphenicol, and low sensitivities to ampicillin, cefoperazone and vancomycin. Prevotella species showed good sensitivities to sulbactam-ampicillin, tazobactam-piperacillin, cefmetazole, imipenem, doripenem and metronidazole. Susceptibility rates to other drugs were slightly different depending on the bacterial species. Both Fusobacterium spp. and Porphyromonas spp. showed high sensitivities to many drugs. C. difficile was highly sensitive to vancomycin and metronidazole, having MIC90s of 0.5 µg/mL and ≤2 µg/mL, respectively.


Asunto(s)
Antiinfecciosos/uso terapéutico , Bacterias Anaerobias/efectos de los fármacos , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Farmacorresistencia Bacteriana/efectos de los fármacos , Humanos , Japón , Pruebas de Sensibilidad Microbiana
4.
J Infect Chemother ; 24(4): 262-266, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29248418

RESUMEN

Carbapenemase-producing Enterobacteriaceae (CPE) are increasing worldwide. Rapid and accurate detection of CPE is necessary for appropriate antimicrobial treatment and hospital infection control. However, CPE contains some strains that are difficult to detect depending on genotype and MIC value of carbapenem, and a detection method has not been established. The recently reported modified carbapenem inactivation method (mCIM) has been developed in CLSI M100-S27 as a phenotypic technique for detecting carbapenemase activity. In the present study, we examined mCIM as a new CPE detection method using 207 Enterobacteriaceae isolates in comparison with the three existing screening methods of modified Hodge test, Carba NP test and carbapenem inactivation method and evaluated its performance. Consequently, both the sensitivity and specificity of mCIM were 100%, indicating better results than the conventional screening methods. The mCIM is a useful tool for microbiology laboratories due to its simplicity, clear criteria, cost-effectiveness and availability at any laboratory.


Asunto(s)
Proteínas Bacterianas/metabolismo , Técnicas de Tipificación Bacteriana/métodos , Enterobacteriaceae Resistentes a los Carbapenémicos/aislamiento & purificación , Carbapenémicos/farmacología , Pruebas de Enzimas/métodos , beta-Lactamasas/metabolismo , Técnicas de Tipificación Bacteriana/economía , Enterobacteriaceae Resistentes a los Carbapenémicos/clasificación , Enterobacteriaceae Resistentes a los Carbapenémicos/efectos de los fármacos , Enterobacteriaceae Resistentes a los Carbapenémicos/enzimología , Infecciones por Enterobacteriaceae/microbiología , Pruebas de Enzimas/economía , Pruebas de Sensibilidad Microbiana , Sensibilidad y Especificidad
5.
Kansenshogaku Zasshi ; 91(1): 31-5, 2017 Jan.
Artículo en Japonés | MEDLINE | ID: mdl-30277685

RESUMEN

We treated an extremely rare case of a mycotic aneurysm with infection of an artificial blood vessel by Saccharomyces cerevisiae, which was the first case in Japan. The patient was an 84-year-old woman. Five months before hospitalization, replacement of the ascending aorta was performed for a dissecting aneurysm of the ascending aorta. On regular follow-up examination, she had no symptoms, but accumulation of a liquid was detected around the artificial blood vessel on computed tomography (CT) imaging. She was immediately hospitalized. An emergency operation was performed because of the infected aneurysm, which accompanied infection of the artificial blood vessel. We could not detect any microorganisms in the blood or tissue culture, but we made a diagnosis of S. cerevisiae infection after performing broad-range polymerase chain reaction (PCR), followed by deoxyribonucleic acid (DNA) sequencing analysis. When an infected aneurysm is suspected after imaging analysis, such as CT, in a patient without fever or chest pain and with poor inflammatory reactions, an infected aneurysm caused by a fungus should be considered, even though blood or tissue culture results are negative. It is important to perform histopathological examination using Grocott silver stain and genetic testing (broad-range PCR and DNA sequencing analysis) of the tissue to identify the fungal infection. In the elderly, the number of cases of infection with S. cerevisiae may increase, and these cases may require more attention in the near future.


Asunto(s)
Aneurisma Infectado/etiología , Aorta/microbiología , Saccharomyces cerevisiae , Infecciones Estafilocócicas/complicaciones , Anciano de 80 o más Años , Femenino , Humanos , Saccharomyces cerevisiae/genética , Infecciones Estafilocócicas/tratamiento farmacológico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA